Haleon (LON:HLN) Reaches New 12-Month High – Time to Buy?

Haleon plc (LON:HLN)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as GBX 715.10 ($8.80) and last traded at GBX 370.80 ($4.56), with a volume of 56901801 shares traded. The stock had previously closed at GBX 371.40 ($4.57).

Haleon Stock Down 0.1 %

The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 54.18. The firm has a market capitalization of £33.54 billion, a price-to-earnings ratio of 3,091.67, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The firm has a 50 day moving average price of GBX 375.12 and a two-hundred day moving average price of GBX 371.84.

Insider Activity at Haleon

In related news, insider Alan Stewart bought 33,923 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were acquired at an average cost of GBX 368 ($4.53) per share, for a total transaction of £124,836.64 ($153,682.93). Also, insider Dawn Allen sold 74,679 shares of the business’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.58), for a total transaction of £277,805.88 ($341,999.11). 10.74% of the stock is currently owned by insiders.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.